Wang F - Search Results

1

Implication of IL-17 producing ɑβT and γδT cells in patients with ovarian cancer.

Chen X, Zhang X, Xu R, Shang W, Ming W, Wang F, Wang J. Chen X, et al. Among authors: wang f, wang j. Hum Immunol. 2020 May;81(5):244-248. doi: 10.1016/j.humimm.2020.02.002. Epub 2020 Feb 21. Hum Immunol. 2020. PMID: 32093885

2

Human herpesvirus-6-specific interleukin 10-producing CD4+ T cells suppress the CD4+ T-cell response in infected individuals.

Wang F, Yao K, Yin QZ, Zhou F, Ding CL, Peng GY, Xu J, Chen Y, Feng DJ, Ma CL, Xu WR. Wang F, et al. Microbiol Immunol. 2006;50(10):787-803. doi: 10.1111/j.1348-0421.2006.tb03855.x. Microbiol Immunol. 2006. PMID: 17053315 Free article.

3

CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery.

Wang F, Ye Y, Xu X, Zhou X, Wang J, Chen X. Wang F, et al. Among authors: wang j. J Ovarian Res. 2013 Feb 13;6(1):14. doi: 10.1186/1757-2215-6-14. J Ovarian Res. 2013. PMID: 23402322 Free PMC article.

4

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer.

Xu X, Wang Y, Wang F, Jia L, Zhou Y, Deng F, Qu J, Zhou B, Meng A, Fu B, Chen X, Qian Z, Wang J. Xu X, et al. Among authors: wang f, wang j, wang y. J Ovarian Res. 2013 Apr 25;6:31. doi: 10.1186/1757-2215-6-31. eCollection 2013. J Ovarian Res. 2013. PMID: 23618037 Free PMC article.

5

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

Huang Y, Ma C, Zhang Q, Ye J, Wang F, Zhang Y, Hunborg P, Varvares MA, Hoft DF, Hsueh EC, Peng G. Huang Y, et al. Among authors: wang f. Oncotarget. 2015 Jul 10;6(19):17462-78. doi: 10.18632/oncotarget.3958. Oncotarget. 2015. PMID: 25968569 Free PMC article.

6

Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.

Ke X, Zhang S, Xu J, Liu G, Zhang L, Xie E, Gao L, Li D, Sun R, Wang F, Pan S. Ke X, et al. Among authors: wang f. Cancer Immunol Immunother. 2016 May;65(5):587-99. doi: 10.1007/s00262-016-1825-6. Epub 2016 Mar 21. Cancer Immunol Immunother. 2016. PMID: 27000869 Free PMC article.

7

TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment.

Wu M, Chen X, Lou J, Zhang S, Zhang X, Huang L, Sun R, Huang P, Wang F, Pan S. Wu M, et al. Among authors: wang f. Oncotarget. 2016 Jul 12;7(28):44534-44544. doi: 10.18632/oncotarget.10003. Oncotarget. 2016. PMID: 27322208 Free PMC article.

8

Tumor-associated macrophages promote invasion via Toll-like receptors signaling in patients with ovarian cancer.

Ke X, Zhang S, Wu M, Lou J, Zhang J, Xu T, Huang L, Huang P, Wang F, Pan S. Ke X, et al. Among authors: wang f. Int Immunopharmacol. 2016 Nov;40:184-195. doi: 10.1016/j.intimp.2016.08.029. Epub 2016 Sep 5. Int Immunopharmacol. 2016. PMID: 27608303

9

Gene expression profiling of CD8⁺ T cells induced by ovarian cancer cells suggests a possible mechanism for CD8⁺ Treg cell production.

Wu M, Lou J, Zhang S, Chen X, Huang L, Sun R, Huang P, Pan S, Wang F. Wu M, et al. Among authors: wang f. Cell Prolif. 2016 Dec;49(6):669-677. doi: 10.1111/cpr.12294. Epub 2016 Sep 19. Cell Prolif. 2016. PMID: 27641758 Free PMC article.

10

Changes in regulatory T cells in patients with ovarian cancer undergoing surgery: Preliminary results.

Wu M, Chen X, Lou J, Zhang S, Zhang X, Huang L, Sun R, Huang P, Pan S, Wang F. Wu M, et al. Among authors: wang f. Int Immunopharmacol. 2017 Jun;47:244-250. doi: 10.1016/j.intimp.2017.04.004. Epub 2017 Apr 25. Int Immunopharmacol. 2017. PMID: 28437737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,046 results

Search Page

Filters